Skip to content

Compare Two Different Methods of Ovarian Stimulation On Outcome of In Vitro Fertilization (IVF)

The Evaluation of The Effects of Mild Ovarian Stimulation on IVF(in vitro fertilization ) Results In Comparison With Conventional Method ,The Infertility Center Hospital Patients,2012-2013

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014030516858N1
Enrollment
204
Registered
2014-04-01
Start date
2012-03-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Female Infertility

Interventions

Intervention 1: Control Group(group active control or standard ) :The Cases in This Group Will Be Treated with Conventional Ovarian Stimulation .They Desensitized with OCP ,Sarting on 3th Cycle D
Treatment - Drugs
Control Group(group active control or standard ) :The Cases in This Group Will Be Treated with Conventional Ovarian Stimulation .They Desensitized with OCP ,Sarting on 3th Cycle Day.in Menstrual
Patients in Group With New Treatment(mild Ovary Stimulation) Were Stimulated Clomiphene Citrate 100 mg From Cycle Day Three Through Seven and Continuous Gonadotropin Stimulation With Of r_

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: female patient age 18–35 years; presence of a regular ; proven ovulatory menstruation cycle with a length of 26–35 days, more that 5 million sperm in SA(semen analysis);body mass index (BMI) of 18–30 kg/m ; ?rst IVF attempt . Exclusion criteria:established systemic disease ;ovary and Uterus abnormalities;repeated abortions.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Increase Endometrial Thickness. Timepoint: 2 Days After HCG Injection. Method of measurement: Sonography.;Increase Implantation. Timepoint: 3 week. Method of measurement: Lab Test.;Increase Chemical Pregnancy. Timepoint: 12 Day. Method of measurement: ß-hCG.;Increase Clinical Pregnancy. Timepoint: 3 week. Method of measurement: Sonography.;Decrease Treatment Cost. Timepoint: Delivery Time. Method of measurement: Counting-RIALs.

Secondary

MeasureTime frame
Decrease OHSS Syndrom. Timepoint: Delivery Time. Method of measurement: Counting.;Decrease of Multiple Pregnancy. Timepoint: Delivery Time. Method of measurement: Counting.;Increase Of Follicular Number. Timepoint: 8 Day. Method of measurement: Counting.;Increase Of Ovoocyt Number. Timepoint: 10 Days. Method of measurement: Counting.;Increase Of Embryo Freez. Timepoint: 3week. Method of measurement: Counting.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Sepideh Peyvandi

Mazandaran University of Medical Sciences

drspeynadi@mazums.ac.irhoora_2243@yahoo.comasdvsdpda@yahoo.com+98 15 1226 1700

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026